Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's ...

Its growth is attributed to the anticipated launch of seven late-stage pipeline therapies. The myasthenia gravis (MG) market ...

The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those with a rare muscle-weakness disease ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

Shatara Clark and Ashley Monique is hosting "The Distinguishing Author Circle," June 14th. There will be other authors, ...

In today’s Health Headlines, June is Myasthenia Gravis Awareness Month. What is myasthenia gravis, how is it diagnosed, and ...

Cao Yalin was diagnosed with myasthenia gravis as a child and is unable to walk independently. She has relied on her father, Cao Guangxing, for mobility throughout her 12 years of schooling.

"Snowflakes of Alabama" & "Divas for Divas" hosting a Myasthenia Gravis 1st Awareness Walk called Snowflakes in Sneakers. The walk will happen June 14th.

During last Monday’s meeting, the Matagorda County Commissioners Court proclaimed June as Myasthenia Gravis Awareness Month, ...